Slower rise in health insurance costs is an illusion
The ‘modest’ 4 percent rise in health insurance premiums, when compared with wages, shows things are getting worse, not better, for health care consumers.
Health Care & Life Sciences
Articles
Dermatologists seek ban on minors using tanning beds
Dermatologist Carrie Davis of Bloomington, a member of the Indiana Academy of Dermatology, told the legislative commission Wednesday that skin cancer is the most common type of cancer in the United States.
Survey: Health insurance costs outpace wage gains
Annual premiums for employer-sponsored family coverage climbed nearly 4 percent this year, to top $16,000 for the first time, according to a survey the Kaiser Family Foundation released Tuesday.
Indiana public health continues slide
It’s fair to say that wellness has never gotten more attention in Indiana than it is now. Trouble is, that attention doesn’t seem to be producing change.
Doctor charged with overprescribing painkillers
Dr. Segun Rasaki, 49, prescribed drugs like hydrocodone and methadone to people who didn’t need them, and submitted fraudulent insurance claims such as duplicate billings, according to court documents.
Swapping Obamacare for a single-payer system?
How would a single-payer national health insurance program change the finances for employers, workers, doctors and hospitals?
Federal health overhaul pinches Ivy Tech’s part-time faculty
The community college is cutting hours for part-time professors in response to the health care reform law, which requires employers to provide coverage to part-time employees who work 30 hours a week or more.
‘Sound Medicine’ earning its chops in radio markets across country
Public broadcasting station WFYI-FM 90.1 aims to expand distribution of its locally produced “Sound Medicine” show to include at least 30 radio stations in large- and medium-sized markets in the next two years.
BioCrossroads drops dreams for hospital innovation
In this age of austerity, there’s almost no chance of Indianapolis hospitals creating a Cleveland Clinic-like hub of innovation.
Lilly lung cancer drug raises patient survival in trial
If approved, the drug would be a potent boost to Lilly’s product portfolio. It would also mean a critical new therapy for a cancer that’s proven difficult to treat.
Symbios collapse snares local investors
Symbios Medical Products LLC filed for Chapter 7 bankruptcy liquidation, costing numerous Indianapolis-area angel investors large sums.
A dose of light reading
Starting with this post, I’m going to periodically give you a peek at my reading list. I’ll highlight reports and reportage that I have found either helpful or provocative. I hope you do, too.
OrthoIndy channeling Walmart in comeback bid
The local orthopedic surgeons are presenting themselves as low-cost providers in an attempt to reverse growth restrictions imposed by Obamacare.
Zimmer told to pay Stryker $228 million in patent case
Indiana-based Zimmer Holdings Inc., which lost a February trial against Stryker Corp. over a surgical device patent, was told to pay three times the jury award, plus other costs.
Expect deja vu: Obamacare won’t fix health care
By and large, Obamacare will leave in place the same major problems in the health care systems that existed before the law was passed—in both Indiana and across the nation.
Cook to unleash wave of ear, nose, throat products
Bloomington-based Cook Medical Inc. recently launched two new products and expects to launch eight to 10 more over the next year.
Board suggested busy Evans let go of AIT
Michael Evans was juggling two companies and two newborn twins when his board of directors suggested it was time for a new CEO of AIT Laboratories. He was replaced by venture capitalist Matt Neff on Monday.
Roche to cut local jobs after diabetes-care sales plunge
Roche’s diabetes care unit, which employs more than 900 in Indianapolis, suffered a 14-percent decline in revenue during the first half of 2013. Roche has reportedly put the unit up for sale.
Already a wreck, the worst is yet to come with Obamacare
Obamacare is destined to fail for one key reason: it will make health insurance cost more and buy less.
Venture capitalist Neff replacing Evans as AIT chief
It’s the latest in a string of leadership changes at the testing lab. Neff is coming from CHV Capital, the venture capital arm of Indiana University Health, where he had been CEO.